Related Experiment Videos
A54145, a new lipopeptide antibiotic complex: microbial and chemical modification
D S Fukuda1, M Debono, R M Molloy
1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
The Journal of Antibiotics
|June 1, 1990
Abstract:
A54145 is a complex of acidic lipopeptide antibiotics produced by Streptomyces fradiae NRRL 18158, NRRL 18159, and NRRL 18160. Each antibiotic factor consists of a peptide core bearing an N-terminal acyl substituent. N-Lys-tert-BOC-protected A54145 complex was deacylated by Actinoplanes utahensis; three protected core peptides were isolated. A54145 antibiotic analogs were synthesized by acylation of the tryptophan N-terminus with 2,4,5-trichlorophenyl active esters, followed by deblocking with trifluoroacetic acid.